Bottom line
Is MVAL a good fund? The bottom line
MVAL is a managed large value ETF from VanEck.
It charges 0.5% — about $50 a year on every $10,000 invested, cheaper than 81% of large value funds we track.
It returned +14.0% over one year (as of Dec 31, 2025, per its prospectus).
With $1.8 million in net assets and 46 holdings, its largest position is Kenvue Inc (4.8%) and the top 10 make up 40.5% of the portfolio.
What stands out
- Low cost: cheaper than 81% of large value peers
What to watch
- Small fund ($1.8 million) — small funds are likelier to close
Updated Nov 19, 2026
What MVAL invests in
VanEck Morningstar Wide Moat Value ETF (the Fund) seeks to track as closely as possible, before fees and expenses, the price and yield performance of the Morningstar US Broad Value Wide Moat Focus Index SM (the Index).
"Under normal circumstances, the Fund invests at least 80% of its total assets in securities that comprise the Funds benchmark index. For purposes of this policy, the term assets means net assets plus the amount of any borrowings for investment purposes. The Index is comprised of equity securities of companies that Morningstar, Inc. (Morningstar or the Index provider) determines (a) have sustainable competitive advantages based on a proprietary methodology that considers quantitative and qualitative factors (wide moat companies) and (b) are attractively priced and weighted according to a modified equal weighting scheme that tilts exposure in favor of pure value companies. According to Morningstar, value companies tend to trade at low price ratios (based on metrics like earnings, book value and sales, or high dividend yields) and have low growth rates (based on earnings, sales, book…
From the fund's prospectus (filed Jan 27, 2026).
MVAL performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MVAL | +14.0% | — | — |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What MVAL costs
On a $10,000 investment, MVAL's 0.5% expense ratio costs about $50 a year. The prospectus estimates $2,294 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
MVAL top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Kenvue Inc | 4.76% |
| 2 | Brown-Forman Corp | 4.58% |
| 3 | Bristol-Myers Squibb Co | 4.46% |
| 4 | Danaher Corp | 4.42% |
| 5 | Constellation Brands Inc | 4.24% |
| 6 | Zimmer Biomet Holdings Inc | 4.22% |
| 7 | Clorox Co/The | 4.04% |
| 8 | GE HealthCare Technologies Inc | 3.56% |
| 9 | Masco Corp | 3.19% |
| 10 | NIKE Inc | 2.99% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 40.5% of the fund. See all top 25 holdings and asset mix →